---
title: "Alliance Global Partners Sticks to Its Buy Rating for Soligenix (SNGX)"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/270266966.md"
description: "Alliance Global Partners' analyst James Molloy reiterated a Buy rating for Soligenix (SNGX) with a price target of $10.00, despite the current share price of $1.23. Molloy, who covers the Healthcare sector, has an average return of -25.6% and a 23.50% success rate. Soligenix holds a Moderate Buy consensus among analysts, with a price target consensus of $10.00."
datetime: "2025-12-19T07:25:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270266966.md)
  - [en](https://longbridge.com/en/news/270266966.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270266966.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/270266966.md) | [繁體中文](https://longbridge.com/zh-HK/news/270266966.md)


# Alliance Global Partners Sticks to Its Buy Rating for Soligenix (SNGX)

In a report released yesterday, James Molloy from Alliance Global Partners reiterated a Buy rating on Soligenix, with a price target of $10.00. The company’s shares closed yesterday at $1.23.

### Claim 50% Off TipRanks Premium and Invest with Confidence

-   Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

Molloy covers the Healthcare sector, focusing on stocks such as Pelthos Therapeutics, Opus Genetics, and Talphera. According to TipRanks, Molloy has an average return of \-25.6% and a 23.50% success rate on recommended stocks.

Soligenix has an analyst consensus of Moderate Buy, with a price target consensus of $10.00.

### 相关股票

- [Soligenix (SNGX.US)](https://longbridge.com/zh-CN/quote/SNGX.US.md)

## 相关资讯与研究

- [Alliance Global Partners Sticks to Their Buy Rating for Village Farms International (VFF)](https://longbridge.com/zh-CN/news/278948619.md)
- [Barclays Reaffirms Their Buy Rating on Genmab A/S (0MGB)](https://longbridge.com/zh-CN/news/279006641.md)
- [Stifel Nicolaus Sticks to Its Buy Rating for Xenon (XENE)](https://longbridge.com/zh-CN/news/278819382.md)
- [Eni's Plenitude Enters Biomethane Sourcing Deal in France](https://longbridge.com/zh-CN/news/278520035.md)
- [Goldman Sachs Keeps Their Buy Rating on ENI S.p.A. (0N9S)](https://longbridge.com/zh-CN/news/279108394.md)